MikeCusnirMD

Complementary and Integrative

Medical Director Mount Sinai Comprehensive Cancer Center Division Chief Hematology and Oncology Mount Sinai Comprehensive Cancer Center Miami Beach Florida

Join to view full profile

Dr. Cusnir is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Cusnir's full profile

Already have an account?

Office
4306 Alton Rd
3rd Floor
Miami Beach, FL 33140
Phone+1 305-535-3337

Fax+1 305-535-3324

Education & Training

University of Arizona College of Medicine-TucsonFellowship, Integrative Medicine, 2010 - 2012
University of MarylandFellowship, Hematology and Medical Oncology, 2000 - 2003
Maimonides Medical CenterResidency, Internal Medicine, 1997 - 2000
Pontifical Xavierian UniversityClass of 1994

Certifications & Licensure

FL State Medical License 2003 - 2025
MD State Medical License 2001 - 2004
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Top Doctors:South Florida Castle Connolly, 2012
Top MD Consumers Checkbook

Clinical Trials

S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer Start of enrollment: 2012 Feb 01
Completed
Phase 2
Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC Start of enrollment: 2019 Sep 20
Terminated
Phase 2, Phase 3
A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer Start of enrollment: 2018 Jun 19
Recruiting
Phase 3
Roles: Contact
Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors Start of enrollment: 2023 Jul 13
Recruiting
Phase 2
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

5 citations
Management of Locally Advanced Rectal Cancer: ASCO Guideline.
Aaron J Scott, Erin B Kennedy, Jordan Berlin, Gina Brown, Myriam Chalabi
Journal of Clinical Oncology. 2024-10-01
Sequencing third-line therapies for metastatic colorectal cancer: a guide for determining which therapy to use first.
Mike Cusnir
Clinical Advances in Hematology & Oncology. 2024-06-01
Improving survival in metastatic colorectal cancer through optimized patient selection.
Tanios S Bekaii-Saab, Afsaneh Barzi, Mike Cusnir
Clinical Advances in Hematology & Oncology. 2024-06-01

Press Mentions

Dr. Cusnir on the Role of Ramucirumab in Gastric CancerFebruary 5th, 2020
Novel Agents and Strategies Propelling Progress in Gastric CancerJanuary 3rd, 2020
Immunotherapy Is Giving Some Cancer Patients a New Life When They Had All but Given up | Miami HeraldMay 25th, 2018
Join now to see all